Table 4

Covariates of rapid early rise in heart rate in univariate and multivariate logistic regression analyses

Total study population (n=306)Patients without revealed symptoms during ETT1 (n=219)
UnivariateMultivariateUnivariateMultivariate
OR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P value
Age, year1.05 (1.02 to 1.08)<0.0011.07 (1.03 to 1.12)0.0021.04 (1.01 to 1.0890.0240.99 (0.93 to 1.06)0.817
Female sex1.84 (1.08 to 3.13)0.0252.43 (1.08 to 5.46)0.0104.03 (1.73 to 9.25)0.0016.88 (1.42 to 33.22)0.016
BMI, kg/m2 1.11 (1.04 to 1.18)0.0021.11 (1.01 to 1.23)0.037
Obesity3.89 (2.07 to 7.28)<0.0014.96 (2.13 to 11.57)<0.0013.73 (1.40 to 9.96)0.0091.32 (0.27 to 6.49)0.732
Hypertension2.05 (1.07 to 3.90)0.0291.04 (0.40 to 2.72)0.9352.64 (0.88 to 7.94)0.085
Coronary artery disease1.78 (0.97 to 3.25)0.0633.63 (1.11 to 11.87)0.0338.60 (1.33 to 55.51)0.024
EOA, cm2 0.46 (0.13 to 1.56)0.2132.28 (0.39 to 13.36)0.362
Lower LV FS, %1.06 (1.00 to 1.11)0.0361.07 (1.00 to 1.14)0.037
Lower LV EF, %1.05 (1.01 to 1.10)0.0131.09 (1.02 to 1.16)0.0181.07 (1.01 to 1.13)0.0321.12 (1.01 to 1.24)0.043
Lower Doppler SV, mL1.01 (0.99 to 1.02)0.4531.03 (1.00 to 1.06)0.054
LV mass index, g/m2.7 0.99 (0.98 to 1.02)0.3301.00 (0.97 to 1.03)0.902
Zva, mm Hg/mL/m2 1.32 (1.02 to 1.70)0.0381.14 (0.86 to 1.51)0.3741.26 (0.83 to 1.92)0.286
  • BMI, body mass index; EF, ejection fraction; EOA, effective orifice area; FS, fractional shortening; LV, left ventricular; METs, metabolic equivalents; SV, stroke volume; Zva, valvuloarterial impedance.